Affiliation:
1. University of Hertfordshire
2. University of Exeter
3. National Institute for Health Research Applied Research Collaboration South West Peninsula
4. Somerset NHS Foundation Trust
5. Classic Care (Devon) Homes Ltd
6. Somerset Care Ltd
Abstract
Abstract
Background
Care home residents often have multiple long-term conditions and experience polypharmacy. However, some medicines may be unnecessary or may cause more harm than good, especially as residents develop increasing frailty. Previous research has found that deprescribing (the reduction or stopping of prescription medicines that may no longer be providing benefit) is generally safe, but it is not known how to make it work well in care homes. Implementation of deprescribing for care home residents can be challenging due to different stakeholders’ concerns and differences in management structures. The paper reports on an investigation of factors that may help or hinder deprescribing practice within care homes.
Methods
Semi-structured interviews with care home staff, residents, family members, and healthcare professionals were conducted regarding their experiences and perceptions of deprescribing. The design, data collection, and framework analysis were informed by the Consolidated Framework for Implementation Research.
Results
Thirty-six semi-structured interviews were conducted with 23 care home staff, 8 residents, 4 family members, and 1 general practitioner. Major themes concerned deprescribing as a complex process and internal and external contextual factors influencing deprescribing practice, including beliefs, abilities, and relationships. The quality of local relationships with and support from healthcare professionals were more crucial factors than the type of care home management structure.
Conclusions
Several influencing factors need to be considered for implementing deprescribing for older adults in care homes. Further work is warranted to design and implement a deprescribing approach which addresses these determinants. Deprescribing implemented safely and successfully in care homes can benefit residents and the wider health economy.
Publisher
Research Square Platform LLC
Reference44 articles.
1. Specialist Pharmacy Service. Understanding polypharmacy, overprescribing and deprescribing: NHS; 2022 [Available from: https://www.sps.nhs.uk/articles/understanding-polypharmacy-overprescribing-and-deprescribing/.
2. Department of Health and Social Care. Good for you, good for us, good for everybody: A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions. 2021.
3. Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-centre study;Izza MAD;Eur Geriatr Med,2020
4. Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation: making it safe and sound. London: The King’s Fund; 2013.
5. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies;Kongkaew C;Ann Pharmacother,2008